Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gidal

Showing results (21-30 of 274) with videos related to

Pageof 28
Sort By:
The Annals of Pharmacotherapy|October 24, 1997
Melatonin: therapeutic use in sleep disordersJ E Chase, B E Gidal
Neurology|December 17, 1998
Refractory status epilepticus: response to ketamineR D Sheth, B E Gidal
The Annals of Pharmacotherapy|November 26, 2009
The effect of carbapenem antibiotics on plasma concentrations of valproic acidErin E Mancl, Barry E Gidal
Clinical Therapeutics|July 18, 2003
Gabapentin dosing in the treatment of epilepsyMichael J McLean, Barry E Gidal
Neurologic Clinics|October 21, 2022
Rescue Treatments for Seizure ClustersRobert J Kotloski, Barry E Gidal
Neurology|April 19, 2019
Lamotrigine and hemophagocytic lymphohistiocytosisKimford J Meador, Barry E Gidal
Therapeutic Drug Monitoring|October 16, 1999
Therapeutic monitoring of topiramate: evaluation of the saturable distribution between erythrocytes and plasma of whole blood using an optimized high-pressure liquid chromatography methodB E Gidal, G L Lensmeyer
Epilepsy & Behavior : E&B|November 8, 2017
When adverse effects are seen as desirable: Abuse potential of the newer generation antiepileptic drugsKelsey L Hawkins, Barry E Gidal
Epilepsy & Behavior : E&B|December 11, 2012
QTc prolongation by antiepileptic drugs and the risk of torsade de pointes in patients with epilepsyAshley E Feldman, Barry E Gidal
Therapeutic Drug Monitoring|November 2, 2021
Interindividual Variability in the Bioavailability of Gabapentin Enacarbil Extended Release in Healthy Adults: An Analysis of Data From 6 Phase I StudiesRitu Lal, Aaron Ellenbogen, Barry Gidal
Pageof 28

Showing results (21-30 of 274) with videos related to

Sort By:
Pageof 28
The Annals of Pharmacotherapy|October 24, 1997
Melatonin: therapeutic use in sleep disordersJ E Chase, B E Gidal
Neurology|December 17, 1998
Refractory status epilepticus: response to ketamineR D Sheth, B E Gidal
The Annals of Pharmacotherapy|November 26, 2009
The effect of carbapenem antibiotics on plasma concentrations of valproic acidErin E Mancl, Barry E Gidal
Clinical Therapeutics|July 18, 2003
Gabapentin dosing in the treatment of epilepsyMichael J McLean, Barry E Gidal
Neurologic Clinics|October 21, 2022
Rescue Treatments for Seizure ClustersRobert J Kotloski, Barry E Gidal
Neurology|April 19, 2019
Lamotrigine and hemophagocytic lymphohistiocytosisKimford J Meador, Barry E Gidal
Therapeutic Drug Monitoring|October 16, 1999
Therapeutic monitoring of topiramate: evaluation of the saturable distribution between erythrocytes and plasma of whole blood using an optimized high-pressure liquid chromatography methodB E Gidal, G L Lensmeyer
Epilepsy & Behavior : E&B|November 8, 2017
When adverse effects are seen as desirable: Abuse potential of the newer generation antiepileptic drugsKelsey L Hawkins, Barry E Gidal
Epilepsy & Behavior : E&B|December 11, 2012
QTc prolongation by antiepileptic drugs and the risk of torsade de pointes in patients with epilepsyAshley E Feldman, Barry E Gidal
Therapeutic Drug Monitoring|November 2, 2021
Interindividual Variability in the Bioavailability of Gabapentin Enacarbil Extended Release in Healthy Adults: An Analysis of Data From 6 Phase I StudiesRitu Lal, Aaron Ellenbogen, Barry Gidal
Pageof 28